Aims: To investigate changes in cardiovascular risk factors over 14 years in relation to diabetes status.
Methods: The study is based on 10,327 subjects who attended the Tromsø Study in 1994 and were screened again in 2007–8. At baseline there were 79 prevalent cases, and 397 incident cases of type 2 diabetes mellitus (DM2) were diagnosed between 1994 and 2008.
Results: Cases with DM2 had decreasing levels of high-density lipoprotein cholesterol (HDL-C), total cholesterol and blood pressure (BP) and increasing levels of triglycerides, body mass index (BMI), and anti-hypertensive treatment during 14 years of follow-up. Despite decreasing BP, more than 75% of the treated cases had BP above 135/80 at the end of follow-up. Similarly, less than 35% of incident cases using statins had low-density lipoprotein cholesterol (LDL-C) below the recommended threshold value of 2.6 mmol/l.
Conclusions: Despite greater relative reduction in cardiovascular risk factors among people with DM2 compared to those without, treatment targets were met in less than 50% of subjects with DM2. Thirteen percent reached the combined targets for glucose, BP and LDL-C control. This indicates a need for more effective strategies to control cardiovascular risk factors especially among individuals with DM2.
MorrishNJWangSLStevensLKFullerJHKeenH. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia2001; 44(Suppl 21): 14–21.
2.
ThomasRJPalumboPJMeltonLJIII. Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970–1994. Arch Intern Med2003; 163: 445–451.
3.
GilmerTPO’ConnorPJRushWA. Predictors of health care costs in adults with diabetes. Diabetes Care2005; 28: 59–64.
4.
FoxCSCoadySSorliePD. Trends in cardiovascular complications of diabetes. JAMA2004; 292: 2495–2499.
5.
EUROASPIRE III. A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil2009; 16: 121–137.
6.
CubbonRMWheatcroftSBGrantPJ. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J2007; 28: 540–545.
7.
JosephJSvartbergJNjølstadISchirmerH. Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Tromsø Study. Eur J Epidemiol2011; 26: 117–214.
8.
ClaudiTCooperJGMidthjellKDaaeCFurusethKHanssenKF. NSAM's guidelines for treatment of diabetes in general practice. Oslo: Norwegian college of general practitioners, Norwegian institute of public health, Norwegian medical association. Norwegian Diabetes Assoc2000(in Norwegian).
9.
Standards of medical care in diabetes – 2009. Diabetes Care2009; 32(Suppl 1): 6–12.
10.
JenssenTGTonstadSClaudiTMidthjellKCooperJ. The gap between guidelines and practice in the treatment of type 2 diabetes. A nationwide survey in Norway. Diabetes Res Clin Pract2008; 80: 314–320.
11.
PreisSRPencinaMJHwangSJ. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation2009; 120: 212–220.
12.
HajjarIKotchenTA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA2003; 290: 199–206.
13.
AparasuRRAparasuA. Hypertension management in outpatient visits by diabetic patients. Res Social Adm Pharm2008; 4: 284–291.
14.
Jiménez-GraciaRHernbndez-BarreraVJiménez-TrujilloIGarridoPCLópez de AndrésAGil de MiguelA. Trends in cardiovascular risk factors and lifestyle behaviors among Spanish adults with diabetes (1993–2003). J Diabetes Complications2010; 23: 394–400.
15.
KoroCEBowlinSJBourgeoisNFedderDO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes. Diabetes Care2004; 27: 17–20.
16.
CzernichowSMennenLBertraisSPreziosiPHercbergSOppertJM. Relationships between changes in weight and changes in cardiovascular risk factors in middle-aged French subjects: effect of dieting. Int J Obes2002; 26: 1138–1143.
17.
Jacobs-van der BruggenMEngelfrietPMHoogenveenRT. Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands. Eur J Cardiovasc Prev Rehabil2008; 15: 521–525.
18.
Eeg-OlofssonKCederholmJNilssonPM. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med2010; 268: 471–482.
19.
MacIsaacRJJerumsG. Intensive glucose control and cardiovascular outcomes in type 2 diabetes. Heart Lung Circ; Published online: August 312010.
20.
WilliCBodenmannPGhaliWAFarisPDCornuzJ. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA2007; 298: 2654–2664.
21.
HuxleyRBarziFWoodwardM. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ2006; 332: 73–78.
22.
SaydahSHFradkinJCowieCC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA2004; 291: 335–342.
23.
Lundby ChristensenLAnker NielsenAAlmdalT. Development in quality of treatment and changes in treatment regimens in complicated type 2 diabetes, Steno Diabetes Center, Gentofte, Denmark. Diabetologia2010; 53(Suppl 1): 405–406.
